RCM Technologies is morphing from a staffing vendor into a mission-critical, IP-enabled infrastructure solutions compounder—powered by a record engineering backlog, mandated school-health demand, and the monetization potential of NEXT.
Overview
RCM Technologies (RCMT) is a long-established (1971) small-cap provider of specialty healthcare, engineering, and life-sciences solutions that has evolved from traditional staffing into an integrated managed-services and engineering partner. FY25 (ended Jan 3, 2026) revenue reached **$319.4M (+14.7% YoY)** with gross profit **$87.9M**, GAAP net income **$16.3M (+22.6%)**, adjusted EBITDA **$30.7M (+18.9%)**, and diluted GAAP EPS **$2.14 (+27.4%)**. The business is concentrated in North America (~90.9% U.S.) with durable relationships in large school districts, utilities, aerospace, and pharma. Growth is anchored by Specialty Health Care (51.4% of revenue) and Engineering (37.7%), with Engineering visibility strengthened by a record **~$70M backlog**. The company’s mid-market agility, regulatory expertise, and proprietary NEXT technology support a narrative of margin expansion and multiple re-rating.